220 related articles for article (PubMed ID: 24282368)
21. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
Wang L; Li HG; Xia ZS; Lü J; Peng TS
Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
[TBL] [Abstract][Full Text] [Related]
22. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
[TBL] [Abstract][Full Text] [Related]
23. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
24. Beclin 1 expression is an independent prognostic factor for gastric carcinomas.
Yu M; Gou WF; Zhao S; Xiao LJ; Mao XY; Xing YN; Takahashi H; Takano Y; Zheng HC
Tumour Biol; 2013 Apr; 34(2):1071-83. PubMed ID: 23334926
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
26. Tumoral FOXP3 expression is associated with favorable clinicopathological variables and good prognosis in gastric adenocarcinoma: the tumor suppressor function of tumoral FOXP3 is related with the P21 expression in gastric adenocarcinoma.
Won KY; Kim GY; Kim HK; Choi SI; Kim SH; Bae GE; Lim JU; Lim SJ
Hum Pathol; 2017 Oct; 68():112-118. PubMed ID: 28882702
[TBL] [Abstract][Full Text] [Related]
27. Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma.
Yu JW; Zhang P; Wu JG; Wu SH; Li XQ; Wang ST; Lu RQ; Ni XC; Jiang BJ
J Exp Clin Cancer Res; 2010 Nov; 29(1):141. PubMed ID: 21054902
[TBL] [Abstract][Full Text] [Related]
28. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
29. Loss of annexin A1 expression in breast cancer progression.
Cao Y; Li Y; Edelweiss M; Arun B; Rosen D; Resetkova E; Wu Y; Liu J; Sahin A; Albarracin CT
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):530-4. PubMed ID: 18776816
[TBL] [Abstract][Full Text] [Related]
30. Up-regulated Annexin A1 expression in gastrointestinal cancer is associated with cancer invasion and lymph node metastasis.
Sato Y; Kumamoto K; Saito K; Okayama H; Hayase S; Kofunato Y; Miyamoto K; Nakamura I; Ohki S; Koyama Y; Takenoshita S
Exp Ther Med; 2011 Mar; 2(2):239-243. PubMed ID: 22977491
[TBL] [Abstract][Full Text] [Related]
31. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of Twist in gastric carcinoma associated with tumor invasion and poor prognosis.
Ru GQ; Wang HJ; Xu WJ; Zhao ZS
Pathol Oncol Res; 2011 Jun; 17(2):341-7. PubMed ID: 21104359
[TBL] [Abstract][Full Text] [Related]
33. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.
Deng H; Wu RL; Zhou HY; Huang X; Chen Y; Liu LJ
World J Gastroenterol; 2006 Feb; 12(7):1013-7. PubMed ID: 16534839
[TBL] [Abstract][Full Text] [Related]
34. Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
Wang G; Gao J; Huang H; Tian Y; Xue L; Wang W; You W; Lian H; Duan X; Wu B; Wang M
BMC Cancer; 2013 May; 13():265. PubMed ID: 23718141
[TBL] [Abstract][Full Text] [Related]
35. Differential expression and prognostic value of ERCC1 and thymidylate synthase in resected gastric adenocarcinoma.
Squires MH; Fisher SB; Fisher KE; Patel SH; Kooby DA; El-Rayes BF; Staley CA; Farris AB; Maithel SK
Cancer; 2013 Sep; 119(17):3242-50. PubMed ID: 23719746
[TBL] [Abstract][Full Text] [Related]
36. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
Sun GG; Sheng SH; Jing SW; Hu WN
Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
38. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma.
Li CF; Shen KH; Huang LC; Huang HY; Wang YH; Wu TF
Pathology; 2010 Jan; 42(1):43-9. PubMed ID: 20025479
[TBL] [Abstract][Full Text] [Related]
39. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
[TBL] [Abstract][Full Text] [Related]
40. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]